Pictet Asset Management Sa Intercept Pharmaceuticals, Inc. Transaction History

Pictet Asset Management Sa

  • $83.4 Billion
  • Q2 2023

A detailed history of Pictet Asset Management Sa transactions in Intercept Pharmaceuticals, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 955,005 shares of ICPT stock, worth $0. This represents 0.01% of its overall portfolio holdings.

Number of Shares
955,005
Previous 694,637 37.48%
Holding current value
$0
Previous $9.33 Million 13.23%
% of portfolio
0.01%
Previous 0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023
BUY
$9.17 - $19.29 $2.39 Million - $5.02 Million
260,368 Added 37.48%
955,005 $10.6 Million
Q1 2023

May 10, 2023
BUY
$12.53 - $21.71 $5.61 Million - $9.73 Million
448,002 Added 181.65%
694,637 $9.33 Million
Q4 2022

Feb 13, 2023
BUY
$11.61 - $16.11 $737,571 - $1.02 Million
63,529 Added 34.7%
246,635 $3.05 Million
Q3 2022

Nov 14, 2022
BUY
$12.21 - $19.7 $315,176 - $508,516
25,813 Added 16.41%
183,106 $2.55 Million
Q2 2022

Aug 09, 2022
BUY
$11.23 - $19.59 $165,844 - $289,305
14,768 Added 10.36%
157,293 $2.17 Million
Q4 2021

Feb 10, 2022
BUY
$14.28 - $19.53 $516,964 - $707,025
36,202 Added 34.05%
142,525 $2.32 Million
Q3 2021

Nov 12, 2021
BUY
$12.99 - $20.47 $1.38 Million - $2.18 Million
106,323 New
106,323 $1.58 Million

Others Institutions Holding ICPT

# of Institutions
6
Shares Held
1.04M
Call Options Held
30K
Put Options Held
5.9K
View Full List

About INTERCEPT PHARMACEUTICALS, INC.

ICPT Quotes by TradingView
  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email